Código QR (código de barras bidimensional)

Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption

Peripheral B cell depletion via anti-CD20 treatment is a highly effective disease-modifying treatment for reducing new relapses in multiple sclerosis (MS) patients. A drawback of rituximab (RTX) and other anti-CD20 antibodies is a poor immune response to vaccination. While this can be mitigated by t...

Fuld beskrivelse

Na minha lista:
Principais autores: Remigius Gröning, Andy Dernstedt, Clas Ahlm, Johan Normark, Peter Sundström, Mattias N. E. Forsell
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2023-07-01
Serier:Frontiers in Immunology
Fag:
multiple sclerosis
vaccination
COVID-19
rituximab
B cell immunology
Online adgang:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219560/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker